Other molecular defects (for example, modification in GNAS methylation) or defects in other mediators of PTH signaling in target tissues (for example, PRKAR1A) may also cause pseudohypoparathyroidism (A) (23). This evidence concerns the gene GNAS and pseudohypoparathyroidism type 1A.